-
Provention Bio Prices $100M Public Offering of Common Stock
Post on 1/13/21
-
Cerecor Closes $36.4M Public Offering of Common Stock
Post on 1/12/21
-
STRATA Skin Sciences Announces Preliminary Fourth Quarter 2020 Financial Results
Post on 1/12/21
-
Tonix Pharmaceuticals Holdings Corp. Prices $40M Common Stock
Post on 1/12/21
-
Antares Pharma Announces Full-Year 2021 Revenue Guidance of $175-200 Million
Post on 1/12/21
-
electroCore Provides Business Update and Select Financial Guidance
Post on 1/12/21
-
Amneal to Acquire Kashiv Specialty Pharmaceuticals
Post on 1/12/21
-
Pfizer Invests $120 Million in Biotechnology Innovation Through the Pfizer Breakthrough Growth Initiative
Post on 1/12/21
-
Vedanta Biosciences Announces $25 Million Investment from Pfizer
Post on 1/12/21
-
Is Johnson & Johnson an Underdog in the Coronavirus Vaccine Race?
Post on 1/12/21
-
My Best Biotech Stock for 2021
Post on 1/11/21
-
Why Pfizer Was a Surprising Loser in 2020 but Could Win Big Time in 2021
Post on 1/11/21
-
Pfizer Stock: A Top Bet for 2021?
Post on 1/8/21
-
Cerecor Proposes Public Offering of Common Stock
Post on 1/7/21
-
CARISMA Therapeutics Completes $47 Million Series B Funding
Post on 1/7/21
-
Onconova Therapeutics Announces $8.7 Million Public Offering
Post on 1/7/21
-
Aquestive Therapeutics Provides Business Update
Post on 1/7/21
-
Pacira Reports Record Revenue for 2020 of $429.6 Million
Post on 1/7/21
-
Is Pfizer Stock a Buy?
Post on 1/7/21
-
AdaptHealth Corp. Public Offering of Class A Common Stock
Post on 1/6/21
-
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Post on 1/6/21
-
Strongbridge Biopharma plc Announces Preliminary Fourth Quarter and Full-Year 2020 Financial Results and Provides Corporate Update
Post on 1/6/21
-
Could Johnson & Johnson Be a Millionaire-Maker Stock?
Post on 1/6/21
-
FDA Opposes Diluting Coronavirus Vaccine Doses From Moderna and Pfizer to Boost Supply
Post on 1/6/21
-
Pfizer Launches First Major Rebranding in Over 70 Years
Post on 1/6/21
Philadelphia
